Male Hypogonadism Monitoring Schedule: When to Test and What to Track on TRT

HealthRX.com

Testosterone checks follow a schedule, not a single test

Print or save as PDF

Key numbers

  • 6 to 12 monthsHow often testosterone is rechecked while on AUA-summarized therapySource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 300 ng/dLAUA total testosterone cutoff below which low levels are diagnosedSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 3 to 6 monthsHematocrit re-evaluation interval after starting Testim gel, before annual checksSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
  • 2.7 mm HgMean rise in 24-hour systolic blood pressure on Testim gel at week 16 (113 men)Source: dailymed.nlm.nih.gov, as cited Nov 7, 2026

At a glance

  • Before treatment / two morning total testosterone measurements on separate days, both low, plus symptoms or signs, and LH and FSH to look for the cause [1][2][3]
  • First-year checks / symptoms, adverse effects, compliance, serum testosterone, hematocrit, prostate cancer risk [1]
  • Testim gel hematocrit checks / before starting, at 3 to 6 months, then annually [3]
  • Testosterone timing / every 6 to 12 months on therapy [2]
  • Treatment target / mid-normal range [1]; the TRAVERSE trial aimed for 350 to 750 ng/dL [4]
  • Prostate / cancer evaluation before and during treatment, with PSA monitored periodically (Testim label) [3]
  • Blood pressure / measured periodically; 24-hour systolic rose 2.7 mm Hg after 16 weeks on Testim gel [3]
  • Fertility / exogenous testosterone suppresses sperm production [1][3]

What the guidelines set out

The Endocrine Society's 2018 guideline sets the shape of follow-up. When treating, it recommends aiming for a mid-normal testosterone concentration with an approved formulation, and monitoring on a standard plan during the first year: evaluate symptoms, adverse effects and compliance, measure serum testosterone and hematocrit, and evaluate prostate cancer risk [1]. The AUA position, as summarized in secondary sources, is to recheck testosterone every 6 to 12 months while on therapy [2].

Before the first dose: confirming the diagnosis

Neither guideline treats a number on its own. The Endocrine Society recommends making the diagnosis only in men with symptoms and signs consistent with testosterone deficiency plus unequivocally and consistently low serum testosterone, starting with a fasting morning total testosterone on an accurate and reliable assay and confirming it by repeating the measurement [1]. The AUA uses a total testosterone cutoff below 300 ng/dL and requires two early-morning total testosterone measurements on separate occasions [2].

If total testosterone is near the lower limit of normal, or a condition alters sex hormone-binding globulin, the Endocrine Society recommends free testosterone by equilibrium dialysis or an accurate formula [1]. Once deficiency is confirmed, it recommends further testing to find the cause, for example LH and FSH to separate testicular failure from a pituitary or hypothalamic problem [1]. The labels say the same in practical terms: confirm that morning serum testosterone has been below the normal range on at least two separate days before starting [3][5].

The lower limit depends on the reference used. In 9,054 men from four cohorts whose assays were harmonized to a CDC reference method, the 2.5th percentile in healthy non-obese men aged 19 to 39 was 264 ng/dL and the median 531 ng/dL [6]. Cut points therefore differ between the harmonized lower limit of about 264 ng/dL and the AUA's 300 ng/dL cutoff [2][6].

What gets measured before treatment

The Testim label calls for hematocrit testing before treatment, prostate cancer evaluation before and during treatment, and periodic PSA monitoring [3]. The Endocrine Society lists an elevated hematocrit, a PSA above 4 ng/mL, a PSA above 3 ng/mL in men at increased risk (for example African American men or men with a first-degree relative with prostate cancer) without further urological evaluation, and a palpable prostate nodule or induration among the conditions where it recommends against starting therapy [1].

The Endocrine Society also recommends against starting testosterone in men planning fertility in the near term and in men with untreated severe obstructive sleep apnea, uncontrolled heart failure, a myocardial infarction or stroke within the last 6 months, or thrombophilia [1].

The first year of treatment

Two questions drive the first year: is the treatment working, and is it causing harm?

Symptom and adverse-effect review, plus a check on compliance, are part of the Endocrine Society's first-year plan, alongside serum testosterone, hematocrit and prostate cancer risk [1]. The Testim label says pre-dose serum testosterone should be assessed periodically, and that if the morning pre-dose concentration is below the normal range the dose is increased to 100 mg [3]. For Testim dose adjustment, the label uses a morning pre-dose testosterone measurement [3].

How often is hematocrit checked on testosterone therapy?

The gel label describes increases in hematocrit, reflecting increased red blood cell mass, that may require lowering or discontinuing testosterone. It adds that an increase in red blood cell mass may raise the risk of thromboembolic events, and it says to check hematocrit before treatment, re-evaluate it 3 to 6 months after starting, and then annually [3]. If hematocrit becomes elevated, the label's instruction is to stop therapy until hematocrit decreases to an acceptable concentration [3]. Polycythemia is a recognized effect of testosterone, and hematocrit is checked before and during treatment [1].

In the Testim clinical trial, clinically notable increases in hemoglobin or hematocrit at the 50 mg dose were similar to placebo. At 100 mg, 2.3% of patients had hemoglobin at or above 19 g/dL and 2.8% had hematocrit at or above 58%, against 1.0% and 1.5% on placebo [3].

PSA and prostate follow-up

The label instructs evaluating patients for prostate cancer before starting and during treatment, monitoring PSA periodically, and monitoring men with benign prostatic hyperplasia for worsening signs and symptoms [3]. The Endocrine Society's first-year plan includes prostate cancer risk evaluation [1]. Separately, FDA asked manufacturers in June 2026 to revise prostate cancer and benign prostatic hyperplasia safety information in testosterone labels; whether each manufacturer has made that change yet is not confirmed [7].

Blood pressure

The Testim label says to measure blood pressure periodically during treatment, especially in men with hypertension, and that the product is not recommended in men with uncontrolled hypertension [3]. In a 4-month study using 24-hour ambulatory monitoring, 113 men on Testim had a mean increase of 2.7 mm Hg systolic (95% CI 0.7 to 4.8) and 1.1 mm Hg diastolic (95% CI -0.1 to 2.3) at week 16 [3]. Among 55 men with hypertension who were already on antihypertensive treatment, the mean increases were 1.9 mm Hg systolic and 0.3 mm Hg diastolic [3]. In TRAVERSE, topical testosterone gel raised mean systolic pressure by 1.0 mm Hg from baseline to 36 months while placebo fell 0.5 mm Hg, a between-group difference of 1.5 mm Hg [3]. The Depo-Testosterone injection label carries a blood pressure warning as well [5].

Testosterone level and target

The Endocrine Society recommends aiming for mid-normal-range concentrations [1]. In TRAVERSE, the 1.62% gel dose was adjusted to keep testosterone between 350 and 750 ng/dL [4]; the Testim label reports a mean level of 440.5 ng/dL at 12 months among men on gel in that trial [3].

Interactions that change what you track

The gel label notes three drug interactions that affect monitoring. Androgens may lower blood glucose and reduce insulin requirements in diabetic patients [3]. Changes in anticoagulant activity can occur, so more frequent INR and prothrombin time monitoring is recommended for men taking warfarin, especially when starting or stopping testosterone [3]. Combining testosterone with corticosteroids may increase fluid retention [3]. Lipid concentrations are on the label's list of labs to monitor periodically [3].

Product-specific points

The Depo-Testosterone label gives a replacement range of 50 to 400 mg every two to four weeks, with dosage adjusted according to the patient's response and the appearance of adverse reactions [5]. Aveed (testosterone undecanoate injection) is available only through a restricted program because of serious pulmonary oil microembolism reactions and anaphylaxis, and patients are observed in the healthcare setting for 30 minutes after each injection [8].

The Testim label carries a boxed warning about secondary exposure: virilization has been reported in children who came into contact with unwashed or unclothed application sites, and children and women should avoid those sites [3].

A practical timeline

Before treatment: two morning total testosterone measurements on separate days, free testosterone if the total is borderline or binding globulin is altered, LH and FSH for the cause, hematocrit, and prostate cancer evaluation including PSA [1][2][3].

3 to 6 months: hematocrit re-evaluation on the Testim label schedule [3].

First year: review of symptoms, adverse effects, compliance, serum testosterone, hematocrit and prostate cancer risk [1].

6 to 12 months: testosterone level [2].

Annually: hematocrit on the Testim label schedule [3].

Periodically: blood pressure, especially in men with hypertension [3]. At any visit: evaluation for deep vein thrombosis or pulmonary embolism if leg pain, swelling, warmth or acute shortness of breath appears [3]; the label also notes sleep apnea may occur in men with risk factors [3].

What people on Reddit report

These are Reddit replies to a question about how often to get blood work on testosterone therapy. Posters describe different schedules and disagree on whether early testing is useful.

JackManstroke · Testosterone

from my understanding every three months in the beginning. Then every six months once you settle on the final dosage. Back to every three months if you make any drastic changes to your proticol.

Describes frequent tests early on, less often once the dose is settled, and more often after any big change.

Read the source discussion

JCMidwest · Testosterone

Did a bunch the first 18-24 months to get everything figured out, now just once a year

Ran many tests in the first stretch of therapy to tune things, then moved to yearly testing once stable.

Read the source discussion

denizen_1 · Testosterone

A month is too early for the first test. My numbers changed a lot from the test I did at a month in for curiosity's sake to tests around 90 days.

Argues that testing at one month is too early, because results shifted a lot compared with later tests.

Read the source discussion

Eastern-Programmer-9 · Testosterone

I got it once a month for thr first 6 months to dial myself in quicker. Every 6 months is not enough, if you dont want to take a year to get everything balanced correctly

Recommends monthly tests at the start to dial in the dose, and says testing only twice a year is not enough.

Read the source discussion

Questions worth asking

Choose the questions you want to keep

Fertility is part of the conversation, not a lab

Exogenous testosterone suppresses sperm production and may lead to azoospermia [3]. The Endocrine Society recommends against starting testosterone in men planning fertility in the near term, and the AUA position is that it should not be prescribed to men currently trying to conceive [1][2]. Separately, hCG is FDA-approved for selected cases of hypogonadotropic hypogonadism due to pituitary deficiency [10], while clomiphene is approved only for ovulatory dysfunction in women and its use in men is off-label [11].

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the Testim gel label, what should happen if hematocrit becomes elevated during treatment?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Frequently asked questions

How often should testosterone levels be checked on TRT?
The AUA position, as summarized, is every 6 to 12 months while on treatment [2]. The Endocrine Society's first-year plan calls for measuring serum testosterone along with hematocrit and symptom review [1]. For Testim gel, the label says pre-dose serum testosterone should be assessed periodically [3].
What is checked before starting testosterone?
Two morning total testosterone measurements on separate days, both low, plus symptoms or signs, and LH and FSH to look for the cause [1][2][3]. Hematocrit is checked and prostate cancer is evaluated [3]. The Endocrine Society recommends against starting with a PSA above 4 ng/mL, or above 3 ng/mL in higher-risk men without further urological evaluation [1].
How often is hematocrit checked during TRT?
The Testim gel label says to check hematocrit before starting treatment, re-evaluate it 3 to 6 months after starting, and then check it annually [3]. If hematocrit becomes elevated, the label's instruction is to stop therapy until it decreases to an acceptable concentration [3].
Does testosterone raise blood pressure?
Yes. In 113 men on Testim monitored over 24 hours, mean systolic pressure rose 2.7 mm Hg and diastolic 1.1 mm Hg at week 16 [3]. In TRAVERSE, systolic pressure rose 1.0 mm Hg on gel versus a 0.5 mm Hg fall on placebo at 36 months [3]. The label says to measure blood pressure periodically, especially in men with hypertension [3].
Does testosterone therapy increase prostate cancer risk?
The gel label states that patients treated with androgens may be at increased risk for prostate cancer and that patients should be evaluated before and during treatment [3]. PSA is on the label's list of labs to monitor periodically [3], and the Endocrine Society includes prostate cancer risk evaluation in its first-year monitoring plan [1].
Does the Testim gel label add any precautions?
The Testim gel label carries a boxed warning about secondary exposure: virilization has been reported in children who contacted unwashed or unclothed application sites, and children and women should avoid those sites [3]. The label also says patients should wash hands after application and cover the site with clothing once the gel has dried [3].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

What are the requirements for a testosterone blood test?

A fasting morning total testosterone measurement on an accurate and reliable assay, repeated to confirm it. The AUA asks for two early-morning total testosterone measurements on separate occasions. If the total is near the lower limit of normal or binding globulin is altered, free testosterone by equilibrium dialysis or an accurate formula is recommended.

How often do you get Blood work??

Testosterone is rechecked every 6 to 12 months while on therapy, according to the AUA position as summarized. Hematocrit is re-evaluated 3 to 6 months after starting Testim gel and then annually, and blood pressure is measured periodically. The Endocrine Society's first-year plan also reviews symptoms, adverse effects, compliance, serum testosterone, hematocrit and prostate cancer risk.

Are test results low enough for TRT?

Not on a single number. The AUA uses a total testosterone cutoff below 300 ng/dL and requires two early-morning measurements on separate occasions. The Endocrine Society recommends confirming a low result by repeating it. In 9,054 men, the 2.5th percentile in healthy non-obese men aged 19 to 39 was 264 ng/dL, so cut points differ depending on the reference used.

References

Show all 12 referencesHide references
  1. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
  2. Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432.
  3. U.S. National Library of Medicine, DailyMed. Testim (testosterone) gel, Endo prescribing information. Testim (testosterone) gel, Endo label
  4. Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107-117.
  5. U.S. National Library of Medicine, DailyMed. Depo-Testosterone (testosterone cypionate) injection, Pfizer prescribing information. Depo-Testosterone (testosterone cypionate) injection, Pfizer label
  6. Travison TG, Vesper HW, Orwoll E, Wu F, Kaufman JM, Wang Y, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161-1173.
  7. Testosterone Information | FDA.
  8. U.S. National Library of Medicine, DailyMed. Aveed (testosterone undecanoate) injection, Endo prescribing information. Aveed (testosterone undecanoate) injection, Endo label
  9. Snyder PJ, Kopperdahl DL, Stephens-Shields AJ, Ellenberg SS, Cauley JA, Ensrud KE, et al. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial. JAMA Intern Med. 2017;177(4):471-479.
  10. U.S. National Library of Medicine, DailyMed. Novarel (chorionic gonadotropin) injection (gonadotrophin, chorionic) prescribing information. Novarel (chorionic gonadotropin) injection (gonadotrophin, chorionic) label
  11. U.S. National Library of Medicine, DailyMed. Clomid (clomiphene citrate) tablets prescribing information. Clomid (clomiphene citrate) tablets label
  12. Reddit participants. How often do you get Blood work?? (r/Testosterone). Accessed 2026-11-10.
Evidence overview for Male Hypogonadism Monitoring Schedule: When to Test and What to Track on TRT